ITGB1 and plasma cell myeloma: While multiple factors play a role in myeloma carcinogenesis, the Very Late Antigen 4 (VLA4, CD49d/CD29, integrin α4β1) is a front-runner implicated in myeloma cell homing, survival and acquisition of cell-adhesion mediated drug resistance (CAM-DR).